# Suet‐Feung Chin

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/suet-feung-chin/

## Facts

| Field | Value |
| --- | --- |
| Citations | 48,160 |
| Field | Cancer Genomics and Diagnostics |
| h-index | 74 |
| i10-index | 132 |
| Last Known Institution | University of Cambridge |
| OpenAlex ID | https://openalex.org/A5021109473 |
| ORCID iD | https://orcid.org/0000-0001-5697-1082 |
| Works | 346 |

## Researcher papers

- [The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups](https://scholariq.org/papers/the-genomic-and-transcriptomic-architecture-of-2-000-breast-tumours-reveals/)
- [Differential oestrogen receptor binding is associated with clinical outcome in breast cancer](https://scholariq.org/papers/differential-oestrogen-receptor-binding-is-associated-with-clinical-outcome-in/)
- [Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer](https://scholariq.org/papers/analysis-of-circulating-tumor-dna-to-monitor-metastatic-breast-cancer/)
- [The clonal and mutational evolution spectrum of primary triple-negative breast cancers](https://scholariq.org/papers/the-clonal-and-mutational-evolution-spectrum-of-primary-triple-negative-breast/)
- [The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes](https://scholariq.org/papers/the-somatic-mutation-profiles-of-2-433-breast-cancers-refine-their-genomic-and/)
- [The landscape of cancer genes and mutational processes in breast cancer](https://scholariq.org/papers/the-landscape-of-cancer-genes-and-mutational-processes-in-breast-cancer/)
- [Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA](https://scholariq.org/papers/non-invasive-analysis-of-acquired-resistance-to-cancer-therapy-by-sequencing-of/)
- [Multi-omic machine learning predictor of breast cancer therapy response](https://scholariq.org/papers/multi-omic-machine-learning-predictor-of-breast-cancer-therapy-response/)
- [Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer](https://scholariq.org/papers/multifocal-clonal-evolution-characterized-using-circulating-tumour-dna-in-a-case/)
- [Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups](https://scholariq.org/papers/dynamics-of-breast-cancer-relapse-reveal-late-recurring-er-positive-genomic/)
- [Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer](https://scholariq.org/papers/personalized-circulating-tumor-dna-analysis-to-detect-residual-disease-after/)

## Researcher topics

- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Cancer-related Molecular Pathways](https://scholariq.org/topics/cancer-related-molecular-pathways/)
- [Genomic variations and chromosomal abnormalities](https://scholariq.org/topics/genomic-variations-and-chromosomal-abnormalities/)
- [Gene expression and cancer classification](https://scholariq.org/topics/gene-expression-and-cancer-classification/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)

## Researcher university

- [University of Cambridge](https://scholariq.org/institutions/university-of-cambridge/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.